# OrigiMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/origimed

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.origimed.com
- Total disclosed funding: $10M
- Latest round: Series B (Nov 19, 2018)
- Investors on record: 5

## About

Established in 2016 and based in Shanghai, China, OrigiMed operates and develops detecting techniques to detect any abnormal genetic information for cancer. It also provides medical counseling service for patients.

## Funding rounds

- Series B, Nov 19, 2018 — Grand Flight Investment, Weidu Capital
- Series A, Dec 20, 2017 — StarVC
- Angel, Sep 19, 2016, $10M — IDG Capital, Green Pine Capital Partners

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Angel
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Angel
- StarVC (https://capitalatlas.ai/funds/starvc) — Series A
- Grand Flight Investment (https://capitalatlas.ai/funds/grand-flight-investment) — Series B
- Weidu Capital (https://capitalatlas.ai/funds/weidu-capital) — Series B